Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Rehabilitation After Left Ventricular Assist Device Implantation: A Narrative Review.

Journal of clinical medicine·2026
Same author

Impact of Sacubitril/Valsartan on Cardiac Autonomic Function Assessed Using Physiological Data from Implantable Cardioverter-Defibrillators.

Journal of clinical medicine·2026
Same author

A Particular Case of Myocardial Injury.

Diagnostics (Basel, Switzerland)·2025
Same author

Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry.

European journal of heart failure·2025
Same author

Management of arrhythmias in left ventricular assist device recipients.

Heart failure reviews·2025
Same author

Effects of Cardiac Contractility Modulation Therapy on Cardiac Hemodynamics: Focus on Myocardial Work.

Journal of cardiac failure·2025

Related Experiment Video

Updated: May 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Takotsubo cardiomyopathy: do the genetics matter?

Giuseppe Limongelli1, Raffaella D'Alessandro, Daniele Masarone

  • 1Cardiologia SUN, Monaldi Hospital, AO Colli, Second University of Naples, Via L Bianchi, Naples 80100, Italy. limongelligiuseppe@libero.it

Heart Failure Clinics
|April 9, 2013
PubMed
Summary

Genetics may play a role in Takotsubo cardiomyopathy (TTC), a heart condition with unclear causes. Recent advances in genetic sequencing offer new ways to study potential genetic links to TTC.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Related Experiment Videos

Last Updated: May 12, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Takotsubo cardiomyopathy (TTC) is a complex heart condition with poorly understood causes.
  • Observed ethnic and seasonal variations in TTC prevalence suggest potential underlying factors.
  • Recent reports of familial cases highlight a possible genetic component in TTC.

Purpose of the Study:

  • To explore the potential role of genetic mechanisms in the pathogenesis of Takotsubo cardiomyopathy.
  • To investigate how genetic factors might influence or explain TTC development.
  • To review recent advancements in genetic technologies for studying TTC.

Main Methods:

  • Review of recent experimental and clinical observations.
  • Analysis of technological advances in exome capture and DNA sequencing.
  • Exploration of genetic mechanisms potentially involved in TTC pathogenesis.

Main Results:

  • Growing evidence suggests a role for genetics in Takotsubo cardiomyopathy pathogenesis.
  • Familial cases of TTC have been increasingly reported.
  • Genetic sequencing technologies provide new avenues for TTC research.

Conclusions:

  • Genetic factors are increasingly recognized as potential contributors to Takotsubo cardiomyopathy.
  • Further research into genetic mechanisms is crucial for understanding TTC.
  • Advanced sequencing technologies are vital tools for uncovering genetic links to TTC.